logo

Marinus Pharmaceuticals (MRNS)



Trade MRNS now with
  Date
  Headline
3/19/2020 7:33:15 AM Marinus Pharmaceuticals Appoints Sasha Damouni Ellis VP, Investor Relations And Corporate Communications
12/12/2019 7:55:44 AM Marinus Appoints Elan Ezickson To Board
12/9/2019 6:38:51 AM Marinus Pharma Announces Clinical And Regulatory Updates For Its Orphan Seizure Programs
10/17/2019 7:37:49 AM Marinus Says Phase 2 Clinical Data On Ganaxolone In RSE Presented At Neurocritical Care Society Meeting
9/26/2019 7:34:48 AM Marinus Pharma Announces Positive Top-Line Results With Ganaxolone In Phase 2 Refractory Status Epilepticus Trial
3/6/2019 7:43:25 AM Marinus Pharma Initiates Phase 3 Study In Children With PCDH19-Related Epilepsy
12/26/2018 12:40:01 AM 8 Biotech Stocks To Watch This Week
12/12/2018 8:39:26 PM Marinus Pharma Prices Underwritten Public Offering Of 12 Mln Shares At $3.75/shr
12/11/2018 4:04:25 PM Marinus Pharmaceuticals Announces Public Offering Of Common Stock
12/10/2018 7:36:21 AM Marinus Pharma Announces Positive Ganaxolone Data In Women With Postpartum Depression
12/4/2018 7:36:49 AM Marinus Pharma Says Ganaxolone Data From Its Phase 2 Clinical Trial At AES Annual Meeting
10/10/2018 7:32:04 AM Marinus Pharma Names Rolando Gutíerrez-Esteinou As VP Of Clinical Development And Pharmacovigilance
10/9/2018 4:51:01 PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
9/25/2018 7:32:12 AM Marinus Completes Enrollment In Its Magnolia Postpartum Depression Study
  
 
>